Cobra PzF 170-03-35012Recalls & reported problems
Celonova Biosciences, Inc. · NanoCoated Coronary Stent System · Class 3 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00879397000845), received between Mar 22, 2018 and Dec 17, 2019 — classified as 1 death, 1 injury.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Device Dislodged or Dislocated2
- Failure to Advance1
- Improper or Incorrect Procedure or Method1
Patient problems
- Foreign Body In Patient2
- Angina1
- Bradycardia1
- Cardiac Arrest1
- Death1
- Ischemia1
- Low Blood Pressure/ Hypotension1
- Myocardial Infarction1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryDec 17, 2019Device Dislodged or Dislocated; Device Dislodged or Dislocated
ON 22-NOVEMBER-2019, PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS PERFORMED AS FOLLOWS FOR TREATMENT OF A LESION IN THE MILDLY TORTUOUS MID LEFT ANTERIOR DESCENDING (MLAD) CORONARY ARTERY: NO PRE-DILATAITON WAS PERFORMED. A 3.5X12MM COBRA PZF¿ NANOCOATED CORONARY STENT SYSTEM WAS UNPACKAGED AND PREPPED PER USUAL PROCEDURE WITHOUT ISSUE; THE TECHNICIAN OBSERVED THE STENT TO REMAIN ON DELIVERY SYSTEM PRIOR TO USE AND HANDED OFF SYSTEM TO PHYSICIAN, WHO BELIEVED STENT WAS ON DEVICE. THE DELIVERY SYSTEM WAS THEN INSERTED INTO GUIDE CATHETER AND ADVANCED TO LESION WITHOUT DIFFICULTY AND WITHOUT RESISTANCE; THE DEVICE WAS INFLATED AT THE LESION. UPON WITHDRAWAL OF THE DELIVERY SYSTEM, THE PHYSICIAN NOTED THAT THE STENT WAS NOT AT THE LESION SITE AND NOT ON THE DELIVERY SYSTEM. STENT WAS UNABLE TO BE LOCATED VIA IMAGING. ALTHOUGH THE STENT WAS UNABLE TO BE FOUND IN ANATOMY ANGIOGRAPHICALLY, OR IN THE CATH LAB, THE PHYSICIAN IS UNABLE TO CONFIRM IF STENT REMAINS IN PATIENT ANATOMY. PLAQUE SHIFT AND DISSECTIONS WERE NOTED ON ANGIOGRAPHY, BUT WERE NOT FLOW-LIMITING. THE TARGET LESION WAS TREATED VIA DEPLOYMENT OF A DRUG-ELUTING STENT. NO ADVERSE EVENTS WERE NOTED DURING OR IMMEDIATELY AFTER
Patient problems: Foreign Body In Patient
MAUDE report 9480826 ↗DeathMar 22, 2018Improper or Incorrect Procedure or Method; Failure to Advance; Device Dislodged or Dislocated; Improper or Incorrect Procedure or Method; Failure to Advance; Device Dislodged or Dislocated
SUBSEQUENT TO THE INITIAL FILED MEDWATCH REPORT, ADDITIONAL INFORMATION WAS RECEIVED, RESULTING IN THE FOLLOWING REVISED EVENT DESCRIPTION: A (B)(6) MALE PRESENTED WITH A MEDICAL HISTORY OF ANGINA PECTORIS WITH MULTIVESSEL DISEASE, TYPE 2 DIABETES, PERIPHERAL VASCULAR DISEASE, CHRONIC RENAL DISEASE, OSTEOMYELITIS IN THE FOOT, BENIGN PROSTATIC HYPERPLASIA (BPH) WITH MINIMAL INVASIVE SURGERY PERFORMED (DATE NOT STATED) AND POLYNEUROPATHY. IN (B)(6) 2017, HE WAS RECOMMENDED FOR CORONARY ARTERY BYPASS SURGERY (CABG). IN (B)(6) 2017, THE PATIENT SOUGHT A SECOND OPINION. A REVIEW OF HIS PRIOR ANGIOGRAM SHOWED SIGNIFICANT LESION IN THE OSTIUM OF THE LEFT CIRCUMFLEX (LCX) AND SUBSEQUENTLY, PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS RECOMMENDED AFTER ADDRESSING HIS BPH SURGERY TO MINIMIZE HIS RISK OF BLEEDING. ON (B)(6) 2018, THE PATIENT WAS ADMITTED FOR PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA). THE PATIENT MEDICATIONS ON ADMISSION: ATORVASTATIN, AVODART, ASPIRIN, FLOMAX AND PLAVIX. DISCONTINUED METFORMIN RECENTLY. ON (B)(6) 2018, THE PATIENT UNDERWENT A PTCA VIA RIGHT RADIAL APPROACH. A JACKY CATHETER WAS USED TO PERFORM THE DIAGNOSTIC ANGIOGRAM OF BOTH THE LEFT AND RIGHT CO
Patient problems: Angina; Bradycardia; Cardiac Arrest; Death; Foreign Body In Patient; Ischemia; Low Blood Pressure/ Hypotension; Myocardial Infarction; Occlusion; Pulmonary Edema; Vasoconstriction; Ventricular Fibrillation; Ventricular Tachycardia
MAUDE report 7364587 ↗
Other Stent, Coronary devices
- WALLSTENT® Endoprosthesis H965403130Boston Scientific Corporation · STENT, CORONARY35 reports
- WALLSTENT® Endoprosthesis H965402130Boston Scientific Corporation · STENT, CORONARY23 reports
- Tryton Side Branch Stent T5-2530-191-USTryton Medical, Inc. · Stent, Coronary1 death22 reports
- WALLSTENT® Endoprosthesis H965403330Boston Scientific Corporation · STENT, CORONARY21 reports
- WALLSTENT® Endoprosthesis H965403320Boston Scientific Corporation · STENT, CORONARY10 reports
- WALLSTENT® Endoprosthesis H965403120Boston Scientific Corporation · STENT, CORONARY9 reports
- Tryton Side Branch Stent T5-3035-151-USTryton Medical, Inc. · Stent, Coronary2 deaths7 reports
- MULTI-LINK VISION 1007850-15Abbott Vascular Inc. · STENT, CORONARY7 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page